Insulin-like growth factors and their carrier proteins in kidneys of rats with experimental diabetes, malignant tumor, and their combination

Persistent hyperglycemia resulting from diabetes mellitus causes microvascular lesions and long-term diabetic complications, such as nephropathy.The aim of the study was to analyze the levels of insulin-like growth factors (IGFs), their carrier proteins (IGFBP), and markers of kidney tissue damage (IL-18, L-FABP, cystatin C, NGAL, and KIM-1) in male rats with diabetes mellitus, tumor growth, and their combination.Materials and methods. The study included white outbred male rats (n = 32) weighing 180–220 g. The animals were divided into four groups (n = 8 each): group 1 – intact animals; controls (2) – animals with diabetes mellitus; controls (3) – animals with Guerin carcinoma; experimental group (4) – animals with Guerin carcinoma against the background of diabetes mellitus. Levels of IGF-1, IGF-2, IGFBP-1, IGFBP-2 and markers of acute kidney injury (IL-18, L-FABP, cystatin С, NGAL, and KIM-1) were determined in the kidney homogenates using enzyme-linked immunosorbent assay.Results. Increased levels of acute kidney injury markers were found in the kidneys of male rats with diabetes mellitus alone and in combination with Guerin carcinoma. In the animals with diabetes mellitus, the levels of IGF-1, IGFBP-1, and IGFBP-2 were decreased on average by 1.3 times, and the level of IGF-2 was increased by 2.1 times compared with the values in the intact male rats. The elevation of IGF-2 / IGF-1 on average by 2.8 times indicated increasing hypoglycemia in the kidney tissue of the animals with diabetes mellitus and in the experimental group with diabetes mellitus and Guerin carcinoma. In the kidney tissues of the rats with Guerin carcinoma, IGF-1 and IGF-2 were elevated on average by 1.5 times, and IGFBP-2 was decreased by 1.7 times. In the animals with malignant tumors growing against the background of diabetes mellitus, IGF-2 and IGFBP-1 were increased by 2.3 and 1.7 times, respectively, and the levels of IGF-1 and IGFBP-2 were similar to those in the intact animals.Conclusion. The study demonstrated abnormalities in the metabolic profile of the kidneys in male rats with experimental diabetes mellitus, Guerin carcinoma, and their combination.

[1]  Ziyan Wang,et al.  Acute Hyperglycemia May Induce Renal Tubular Injury Through Mitophagy Inhibition , 2020, Frontiers in Endocrinology.

[2]  S. K. Pal,et al.  Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement , 2020, Diabetes Therapy.

[3]  Mina Wang,et al.  Diabetes and cancer: Epidemiological and biological links , 2020, World journal of diabetes.

[4]  T. P. Protasova,et al.  О РАСШИРЕНИИ ВАРИАНТОВ ИСПОЛЬЗОВАНИЯ МЫШЕЙ BALB/C NUDE ДЛЯ ЭКСПЕРИМЕНТАЛЬНОГО ИЗУЧЕНИЯ ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ ЧЕЛОВЕКА IN VIVO , 2020 .

[5]  Xiaolei Tang,et al.  IGF-1 Deficiency Rescue and Intracellular Calcium Blockade Improves Survival and Corresponding Mechanisms in a Mouse Model of Acute Kidney Injury , 2020, International journal of molecular sciences.

[6]  Xiao-ming Meng,et al.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression , 2020, Signal Transduction and Targeted Therapy.

[7]  Yusuke Suzuki,et al.  Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease , 2019, Journal of diabetes investigation.

[8]  A. Czarnecka,et al.  Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators , 2019, Journal of Cell Communication and Signaling.

[9]  S. Rosen,et al.  Why Have Detection, Understanding and Management of Kidney Hypoxic Injury Lagged behind Those for the Heart? , 2019, Journal of clinical medicine.

[10]  R. Faragher,et al.  Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing , 2018, Biogerontology.

[11]  Javier Díez Espino,et al.  Chronic renal disease in Spain: Prevalence and related factors in persons with diabetes mellitus older than 64 years , 2018, Nefrología (English Edition).

[12]  C. Ronco,et al.  Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption , 2017, Clinical chemistry and laboratory medicine.

[13]  K. Budde,et al.  Biomarkers in acute kidney injury – pathophysiological basis and clinical performance , 2017, Acta physiologica.

[14]  A. Levin,et al.  Chronic kidney disease , 2017, Nature Reviews Disease Primers.

[15]  Zengbin Wu,et al.  IGF-1 protects tubular epithelial cells during injury via activation of ERK/MAPK signaling pathway , 2016, Scientific Reports.

[16]  M. Prostran,et al.  Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations. , 2016, Current medicinal chemistry.

[17]  E. Hanse,et al.  Erratum: Structural Mechanism for Regulation of Bcl-2 protein Noxa by phosphorylation , 2015, Scientific Reports.

[18]  Елена Михайловна Франциянц,et al.  Роль маркеров острого повреждения почек в выборе тактики хирургического лечения больных раком почки , 2015 .

[19]  Y. Shibagaki,et al.  Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia , 2015, PloS one.

[20]  L. Bach,et al.  Insulin-like growth factors and kidney disease. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  L. Chawla,et al.  Biomarkers of renal function, which and when? , 2015, Clinica chimica acta; international journal of clinical chemistry.